Yes, lesbians can get herpes. Herpes simplex virus spreads through direct skin-to-skin contact with an infected person's oral or genital mucosa, and sex between women involves exactly that contact. HSV-1 and HSV-2 do not care about sexual orientation, only about friction, mucosal surfaces, and viral shedding. Roughly 1 in 6 US adults aged 14 to 49 carries genital HSV-2, and about half carry HSV-1 orally, so any new partner carries real transmission risk regardless of gender.

How Herpes Spreads Between Women

Transmission requires three things at once: a mucosal or broken-skin surface, virus present on the other person's skin, and enough friction or contact time to move it. Vaginal fluid and genital skin both carry HSV-2 during shedding. Saliva and lip skin carry HSV-1. When a woman performs oral sex on a partner, she is delivering virus from her mouth to a mucous membrane. When two women rub genitals together, they exchange genital skin contact directly.

The mechanism that surprises most people is asymptomatic shedding. Virus leaves the skin on roughly 10 to 20 percent of days even when no sore is visible, per decades of shedding studies summarized by the CDC. That means the "she looked fine" reasoning fails as a prevention strategy. In plain terms: the absence of symptoms is not the absence of virus.

HSV-1 and HSV-2 behave differently here. HSV-1 causes most oral herpes and a growing share of genital herpes, especially in women under 25. HSV-2 almost always causes genital infection and sheds more often from the genitals, making it the more transmissible genital type between women.

Quantified Transmission Risk

A landmark 2011 study by Wald and colleagues followed 199 couples where one partner had genital HSV-2 and tracked transmission over a median of 334 days. The overall rate was about 10 percent per year of exposure without antivirals or condoms. That figure applies to heterosexual couples; the equivalent female-to-female rate is not as precisely measured, which is itself an honest caveat.

Per-act risk is smaller but real. Research on HSV-2 estimates transmission at roughly 0.1 to 1 percent per act of unprotected sex when the source partner is shedding. Over a year of regular sex, those per-act risks compound toward the annual figure.

Two factors push the number higher. First, viral shedding frequency: HSV-2 sheds on about 15 to 20 percent of days in the first year after infection, dropping toward 10 percent later. Second, immune status and mucosal damage. Any break in the skin, including from vigorous sex or shaving, raises risk.

Factor Effect on transmission risk Approximate magnitude
Asymptomatic shedding Increases risk without visible signs Virus present 10-20% of days
Antiviral therapy (daily) Reduces shedding and transmission Cuts transmission about 48%
Condom or barrier use Reduces skin contact Cuts transmission about 30-50%
Active outbreak Highest risk window Avoid contact entirely
First year of infection Higher shedding frequency Up to 2x later years

Oral Herpes and Cold Sores During Sex

Roughly half of US adults carry HSV-1, most of it oral, per CDC seroprevalence data. That matters because oral sex is common between women and mouth-to-genital contact is an efficient HSV-1 route. A cold sore is contagious from the first tingle until the scab heals, a window of about 7 to 10 days. Contact during that window carries the highest risk.

The counterintuitive correction: many genital HSV-1 infections come from a partner with no visible cold sore, because HSV-1 also sheds silently. People who have never had a cold sore can still transmit HSV-1.

Genital-to-Genital and Toy Transmission

Skin-to-skin rubbing of vulvas, with or without penetration, transmits HSV-2 directly. The friction and mucosal contact are sufficient. This is the route that explains herpes in women who have never had penetrative sex with a man.

Sex toys add a second vector. Virus on a toy's surface can transfer to a new partner within minutes if not cleaned. HSV survives on hard nonporous surfaces for hours but dies quickly on porous materials like fabric. Cleaning between partners, or using separate toys, closes this gap.

Timeline of a Herpes Infection

The time course matters for testing and for knowing when someone is most contagious.

Stage Timing after exposure What happens
Incubation 2-12 days (average about 4) No symptoms; virus multiplies in skin
Primary outbreak Days 4 onward Blisters, ulcers, flu-like symptoms; most contagious
Healing 1-3 weeks Sores crust and resolve without scarring
Latency After healing Virus retreats to nerve ganglia, invisible
Reactivation Weeks to years later Recurrent outbreaks, usually milder
Shedding Intermittent, lifelong Virus present without symptoms 10-20% of days

Primary outbreaks last longer and hurt more than recurrences. Recurrent genital HSV-2 outbreaks typically last 5 to 10 days and occur several times in the first year, then taper.

Symptoms and the Misconception That It Is Always Visible

Symptoms include tingling, itching, small blisters, ulcers, painful urination, and sometimes fever or swollen glands during a primary episode. But up to 80 to 90 percent of people with HSV-2 have never been diagnosed, per CDC estimates, because they had mild or no recognizable symptoms. Many carriers have no idea.

In plain terms: most people with genital herpes do not know they have it, and that silence is what drives transmission.

A second misconception: herpes is not tested in routine STD panels. Standard screening checks chlamydia, gonorrhea, syphilis, HIV, and trichomonas, but not herpes unless there is a lesion to swab or a specific request. Many women assume a "full STD test" covered herpes. It usually did not.

Testing and Diagnosis

The right test depends on the situation. A swab of an active sore, sent for PCR, is the most reliable test and gives a type-specific answer. When no sore is present, a type-specific blood IgG test can detect antibodies, but timing matters: antibodies take 12 to 16 weeks to appear, so a test soon after exposure can read falsely negative. The CDC does not recommend routine blood screening for herpes in people without symptoms, because a positive result without a lesion can cause distress without changing management for most.

For a woman with symptoms, a swab is definitive. For a woman with a partner known to carry HSV-2 and no symptoms of her own, a clinician may still order a type-specific IgG test to establish baseline status.

What to Actually Do

Concrete steps reduce risk and manage an existing infection.

  • Use barrier methods. Condoms and dental dams cut transmission, though they do not eliminate it because skin outside the barrier can still touch.
  • Ask partners about cold sores and outbreaks, and avoid oral contact during a visible sore, from tingling through healing.
  • Take daily antiviral therapy (acyclovir or valacyclovir) if you or a partner has HSV-2. Daily suppression cuts transmission by about 48 percent and reduces outbreak frequency.
  • Clean sex toys between partners and do not share them unwashed.
  • Get a type-specific swab test during any suspicious sore, and a blood IgG test only if a clinician advises it after a known exposure.
  • Tell partners before sex if you carry HSV-2. Disclosure plus antivirals is the combination with the strongest evidence base.

Limitations and What Science Does Not Yet Know

The female-to-female transmission rate for HSV-2 has not been measured with the precision of the heterosexual rate, so the 10 percent annual figure is a reasonable proxy, not a direct measurement. Studies on women who have sex with women are fewer and smaller.

Vaccines remain unproven. Several candidates have entered trials, but none is approved as of 2026. Antivirals reduce transmission without eliminating it, so "undetectable" is not a concept that applies to herpes the way it does to HIV.

Finally, stigma is not a clinical variable. The virus does not distinguish orientation, and neither should risk counseling. The mechanisms, the numbers, and the protective steps are the same regardless of who is having sex with whom.